WallStreetZenWallStreetZen

AnalystsWilliam Plovanic
William Plovanic's Stock Forecasts

Analyst Ranking
Top 27%
#1232 out of 4529 analysts
Average Return
+2.57%
Win Rate
47%36 out of 77
Risk vs Reward
Poor
Good

William Plovanic's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Transmedics Group IncTMDX
+243.26%$22.17$76.10
2022-03-16 -
2023-03-16
Strong Buy
Y Mabs Therapeutics IncYMAB
+167.00%$6.09$16.26
2023-07-24 -
2024-03-28
Strong Buy
Y Mabs Therapeutics IncYMAB
+99.26%$8.16$16.26
2023-06-06 -
2024-03-28
Strong Buy
Edwards Lifesciences CorpEW
+81.45%$11.05$20.05
2013-10-29 -
2014-10-30
Strong Buy
Y Mabs Therapeutics IncYMAB
+76.16%$9.23$16.26
2023-05-08 -
2024-03-28
Strong Buy

William Plovanic's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Inari Medical IncNARI
7Strong Buy$75.00+56.32%Maintains
a month ago
Penumbra IncPEN
4Strong Buy$284.00+27.25%Reiterates
a month ago
Irhythm Technologies IncIRTC
6Strong Buy$133.00+14.66%Maintains
a month ago
Nevro CorpNVRO
8Hold$23.00+59.28%Downgrades
3 months ago
Bioventus IncBVS
1Strong Buy$7.00+34.62%Upgrades
4 months ago
Boston Scientific CorpBSX
5Strong Buy$64.00-6.56%Maintains
4 months ago
Pulmonx CorpLUNG
4Strong Buy$12.00+29.45%Maintains
5 months ago
Angiodynamics IncANGO
3Strong Buy$17.00+189.61%Maintains
6 months ago
Merit Medical Systems IncMMSI
4Hold$70.00-7.59%Maintains
7 months ago
Staar Surgical CoSTAA
5Hold$48.00+25.39%Downgrades
8 months ago
Y Mabs Therapeutics IncYMAB
3Strong Buy$22.00+35.30%Maintains
8 months ago
Transmedics Group IncTMDX
3Strong Buy$86.00+16.31%Maintains
10 months ago
Shockwave Medical IncSWAV
5Strong Buy$307.00-5.72%Maintains
a year ago
Neuronetics IncSTIM
1Strong Buy$7.00N/AMaintains
a year ago
Atricure IncATRC
6Strong Buy$74.00N/AMaintains
a year ago
Cvrx IncCVRX
2Strong Buy$23.00N/AMaintains
a year ago
Edwards Lifesciences CorpEW
16Hold$76.00N/AMaintains
a year ago
Vapotherm IncVAPO
2Hold$40.00N/ADowngrades
2 years ago
Acutus Medical IncAFIB
4Hold$3.00N/ADowngrades
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.